Optimization of osteoporosis and osteopenia management among renal transplant recipients

Future Journal of Pharmaceutical Sciences

Table 3 Spinal T-scores at baseline and after one year of treatment

	Baseline	After 1 year	Net change	P value
Spinal Osteoporosis
Denosumab	−3.13 (± 0.6)	−2.4 (± 0.41)	0.73	0.008^b
Ibandronate	−2.8 (± 0.3)	−3 (± 0.37)	−0.2	0.178^a
Spinal Osteopenia
Denosumab	−1.9 (± 0.27)	−1.5 (± 0.32)	0.4	0.015^b
Ibandronate	−1.6 (± 0.15)	−1.55 (± 0.5)	0.05	0.97^a

The Student T-test was used for normally distributed variables; significance was found at P ≤ 0.05
^aNonsignificant difference between the two groups. ^b Significant difference between the two groups